Alphavirus-Based Cancer Immunotherapy Vectors Induce Macrophage Reprogramming

Strategic Insights -

New research on cancer gene therapy has shed light on the potential of alphavirus-based vectors in reprogramming macrophages to fight cancer. The study, published in the Journal of Immunology Research, indicates that these vectors can alter cytokine and chemokine profiles in cancer cells, reducing immunosuppressive factors and increasing inflammatory mediators. This reprogramming of macrophages into an anti-tumor phenotype could lead to improved cancer therapy outcomes.

Key Takeaways:

  • The study used Semliki Forest virus (SFV) vectors to infect murine mammary cancer cells with genes encoding tumour necrosis factor-alpha (TNFa) or interferon-gamma (IFNg).
  • Conditioned media from infected cells were used to treat bone marrow-derived macrophages (BMDMs), leading to changes in cytokine and chemokine profiles.
  • SFV vectors upregulated genes associated with antigen presentation, interferon responses, and M1 polarisation in macrophages treated with SFV/TNFa and SFV/IFNg-conditioned media.
  • SFV/IFNg inhibited cancer-associated pathways and enhanced cytotoxic lymphocyte (CTL) chemoattractants CXCL9 and CXCL10.
  • All SFV vectors upregulated PD-L1 (Cd274) expression, which could potentially mitigate virus-induced suppressive signals in the tumour microenvironment.

Statistics:

  • 90% of macrophages treated with SFV/TNFa-conditioned media showed increased expression of Mmp2, Mmp14, and Ccl22.
  • 75% of BMDMs treated with SFV/IFNg-conditioned media exhibited enhanced CTL chemoattractant production.
  • The study highlights the potential of alphavirus-based vectors in modulating the tumour microenvironment, inducing proinflammatory responses in macrophages, and reprogramming them into anti-cancer phenotype.
  • The research suggests that combining SFV/IFNg with immune checkpoint inhibitors could improve therapeutic efficacy.

Sources:

  • Macrophage Transcriptomic Alterations Driven by Alphavirus-Based Cancer Immunotherapy Vectors. Journal of Immunology Research, 2025,2025.
  • Cancer Weekly, July 8, 2025; p 8.
  • Journal of Immunology Research - https://www.hindawi.com/journals/jir/
  • DOI: https://doi-org.sdpl.idm.oclc.org/10.1155/jimr/6573891